<DOC>
	<DOC>NCT02616328</DOC>
	<brief_summary>This is a single-arm, open-label, non-randomized, multicenter trial to evaluate the efficacy and safety of using tocilizumab for confirmed rheumatoid arthritis participants in clinical practice.</brief_summary>
	<brief_title>A Study of the Efficacy and Safety of Tocilizumab for Confirmed Rheumatoid Arthritis (RA) Participants in Clinical Practice</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<criteria>Diagnosed with moderatetosevere active rheumatoid arthritis (RA) for over 3 months Started on tocilizumab, with or without previous history of biological treatment Pregnant or lactating women Treated with an investigational drug within 30 days prior to initiation of study drug Having a condition that, in the opinion of the investigator, could compromise the participant's safety or interfere with the study results</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>